The DNA repair protein O6-methylguanine-DNA methyltransferase protects against skin tumor formation induced by antineoplastic chloroethylnitrosourea.

Abstract:

:Chloroethylnitrosoureas (CNUs) are being used in the therapy of various neoplastic diseases, including skin cancer. Because secondary tumor formation is a serious threat in chemotherapy with these drugs, we explored whether and to what extent the DNA repair protein DNA-O6-methylguanine:protein-L-cysteine S-methyltransferase (MGMT) protects against CNU-induced tumors. We made use of transgenic mice overexpressing human MGMT in their skin and the initiation-promotion protocol on treatment with 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea (ACNU, nimustine) that is representative of CNUs. ACNU applied topically as a single low dose to the dorsal skin was highly effective in tumor induction in nontransgenic mice, whereas in cytokeratin MGMT transgenic mice, tumor formation was remarkably reduced. ACNU-induced skin tumors harbored mutations in the c-Ha-ras gene in both groups of mice. The results provide clear evidence that MGMT exerts protection against CNU-induced cancer. Our data also indicate that O6-chloroethylguanine, which is repaired by MGMT, is a main precarcinogenic CNU-induced DNA lesion.

journal_name

Cancer Res

journal_title

Cancer research

authors

Becker K,Gregel CM,Kaina B

subject

Has Abstract

pub_date

1997-08-15 00:00:00

pages

3335-8

issue

16

eissn

0008-5472

issn

1538-7445

journal_volume

57

pub_type

杂志文章
  • In vivo efficacy of a novel inhibitor of selected signal transduction pathways including calcium, arachidonate, and inositol phosphates.

    abstract::Aberrant signal transduction has been implicated in malignant transformation, growth, and progression. This has led to the proposal to use inhibitors of signal transduction pathways to treat cancer. One approach to circumventing potential toxicity and improving efficacy would be to target pathways upon which cancer ce...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Kohn EC,Sandeen MA,Liotta LA

    更新日期:1992-06-01 00:00:00

  • Insulin reversal of cancer cachexia in rats.

    abstract::The anabolic effects of exogenous neutral protamine hagedorn insulin on tumor-bearing (TB) and non-tumor-bearing (NTB) rats were examined. Exogenous insulin (2 units/100 g/day) produced similar hypoglycemia in TB and NTB rats. Food intake and body weight gain were significantly increased by insulin in NTB rats. In TB ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Moley JF,Morrison SD,Norton JA

    更新日期:1985-10-01 00:00:00

  • Cyclin D1 activity regulates autophagy and senescence in the mammary epithelium.

    abstract::Overexpression of cyclin D1 is believed to endow mammary epithelial cells (MEC) with a proliferative advantage by virtue of its contribution to pRB inactivation. Accordingly, abrogation of the kinase-dependent function of cyclin D1 is sufficient to render mice resistant to breast cancer initiated by ErbB2. Here, we re...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-11-4139

    authors: Brown NE,Jeselsohn R,Bihani T,Hu MG,Foltopoulou P,Kuperwasser C,Hinds PW

    更新日期:2012-12-15 00:00:00

  • TLR9 signaling in the tumor microenvironment initiates cancer recurrence after radiotherapy.

    abstract::Cancer radiotherapy may be immunogenic, but it is unclear why its immunogenic effects are rarely sufficient to prevent tumor recurrence. Here, we report a novel Toll-like receptor 9 (TLR9)-dependent mechanism that initiates tumor regrowth after local radiotherapy. Systemic inhibition of TLR9, but not TLR4, delayed tum...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-13-1314

    authors: Gao C,Kozlowska A,Nechaev S,Li H,Zhang Q,Hossain DM,Kowolik CM,Chu P,Swiderski P,Diamond DJ,Pal SK,Raubitschek A,Kortylewski M

    更新日期:2013-12-15 00:00:00

  • Epidermal growth factor-independent transformation of Ba/F3 cells with cancer-derived epidermal growth factor receptor mutants induces gefitinib-sensitive cell cycle progression.

    abstract::Epidermal growth factor receptor (EGFR) plays critical roles in many biological processes and in tumorigenesis. Here, we show that two mutated EGFRs found in lung and other malignancies, EGFR-G719S and EGFR-L858R, could transform Ba/F3 cells to interleukin-3 (IL-3)-independent growth, in a ligand-independent manner, a...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-1829

    authors: Jiang J,Greulich H,Jänne PA,Sellers WR,Meyerson M,Griffin JD

    更新日期:2005-10-01 00:00:00

  • Immunoassay for melanoma-associated proteoglycan in the sera of patients using monoclonal and polyclonal antibodies.

    abstract::A melanoma-associated proteoglycan antigen is expressed by primary cutaneous and ocular melanomas, metastatic melanomas, nevus cells, some astrocytomas, and fetal fibroblasts, and it is shed into culture supernatant by both melanoma and nevus cells. The antigen is also expressed by tumor cells in vivo. Melanoma and ne...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Ross AH,Herlyn M,Ernst CS,Guerry D,Bennicelli J,Ghrist BF,Atkinson B,Koprowski H

    更新日期:1984-10-01 00:00:00

  • Inhibition of RAS-mediated transformation and tumorigenesis by targeting the downstream E3 ubiquitin ligase seven in absentia homologue.

    abstract::Constitutively active RAS small GTPases promote the genesis of human cancers. An important goal in cancer biology is to identify means of countervailing activated RAS signaling to reverse malignant transformation. Oncogenic K-RAS mutations are found in virtually all pancreatic adenocarcinomas, making the RAS pathway a...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-06-4471

    authors: Schmidt RL,Park CH,Ahmed AU,Gundelach JH,Reed NR,Cheng S,Knudsen BE,Tang AH

    更新日期:2007-12-15 00:00:00

  • Human T-cell leukemia virus oncoprotein tax represses nuclear receptor-dependent transcription by targeting coactivator TAX1BP1.

    abstract::Human T-cell leukemia virus type 1 oncoprotein Tax is a transcriptional regulator that interacts with a large number of host cell factors. Here, we report the novel characterization of the interaction of Tax with a human cell protein named Tax1-binding protein 1 (TAX1BP1). We show that TAX1BP1 is a nuclear receptor co...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-06-3053

    authors: Chin KT,Chun AC,Ching YP,Jeang KT,Jin DY

    更新日期:2007-02-01 00:00:00

  • Activity of a novel 4-quinolinecarboxylic acid, NSC 368390 [6-fluoro-2-(2'-fluoro-1,1'-biphenyl-4-yl)-3-methyl-4-quinolinecarb oxylic acid sodium salt], against experimental tumors.

    abstract::A novel, substituted 4-quinolinecarboxylic acid (NSC 339768) demonstrated antitumor activity against L1210 leukemia and B16 melanoma in the National Cancer Institute's Developmental Therapeutics Program. An extensive analogue synthesis program was initiated; over 200 derivatives were synthesized and tested for antican...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Dexter DL,Hesson DP,Ardecky RJ,Rao GV,Tippett DL,Dusak BA,Paull KD,Plowman J,DeLarco BM,Narayanan VL

    更新日期:1985-11-01 00:00:00

  • Expression of DMBT1, a candidate tumor suppressor gene, is frequently lost in lung cancer.

    abstract::DMBT1 is a candidate tumor suppressor gene located at 10q25.3-26.1. Homozygous deletion of the gene was found in a subset of medulloblastoma and glioblastoma multiforme; lack of expression was noted in the majority of these tumors. In adult tissues, DMBT1 is highly expressed only in lung and small intestine tissues, i...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Wu W,Kemp BL,Proctor ML,Gazdar AF,Minna JD,Hong WK,Mao L

    更新日期:1999-04-15 00:00:00

  • Bovine serum albumin-doxorubicin conjugate overcomes multidrug resistance in a rat hepatoma.

    abstract::A bovine serum albumin-conjugated doxorubicin via the glutaraldehyde bridge (BSA-DXR conjugate) showed potent dose-dependent inhibition of cell growth against daunorubicin-resistant AH66 (AH66DR) cells as well as parental AH66 (AH66P) cells in vitro as compared to treatment with DXR or BSA-glutaraldehyde conjugate wit...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Ohkawa K,Hatano T,Yamada K,Joh K,Takada K,Tsukada Y,Matsuda M

    更新日期:1993-09-15 00:00:00

  • Acute effects of tumor necrosis factor alpha or lymphotoxin on global blood flow, laser Doppler flux, and bioenergetic status of subcutaneous rodent tumors.

    abstract::Global blood flow (TBF), tumor vascular resistance, laser Doppler flow in superficial tumor areas, and mean arterial blood pressure were evaluated in rats bearing s.c. DS sarcomas. Measurements were performed before and after i.v. administration of rhTNF-alpha 2 or recombinant human lymphotoxin (rhLT) (1 mg/kg). Upon ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Kluge M,Elger B,Engel T,Schaefer C,Seega J,Vaupel P

    更新日期:1992-04-15 00:00:00

  • Chemotherapy of a human malignant melanoma transplanted in the nude mouse.

    abstract::The effects of single agent therapy with 1-(-chloroethyl)-3-cyclohexyl-1-nitrosourea, 5-fluorouracil, and 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide on a human malignant melanoma transplanted and passed serially in thymusless nude mouse were studied. Tumor response varied. A single dose of 1-(-chloroethyl)-3-...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Povlsen CO,Jacobsen GK

    更新日期:1975-10-01 00:00:00

  • Anticancer drugs induce increased mitochondrial cytochrome c expression that precedes cell death.

    abstract::Recent studies have demonstrated that cytochrome c plays an important role in cell death. In the present study, we report that teniposide and various other chemotherapeutic agents induced a dose-dependent increase in the expression of the mitochondrial respiratory chain proteins cytochrome c, subunits I and IV of cyto...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Sánchez-Alcázar JA,Khodjakov A,Schneider E

    更新日期:2001-02-01 00:00:00

  • Autotaxin hydrolyzes sphingosylphosphorylcholine to produce the regulator of migration, sphingosine-1-phosphate.

    abstract::Autotaxin (ATX) is an exoenzyme that potently induces tumor cell motility, and enhances experimental metastasis and angiogenesis. ATX was shown recently to be identical to serum lysophospholipase D activity, producing lysophosphatidic acid (LPA) from lyso-glycerophospholipids. LPA, itself a strong chemoattractant for ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Clair T,Aoki J,Koh E,Bandle RW,Nam SW,Ptaszynska MM,Mills GB,Schiffmann E,Liotta LA,Stracke ML

    更新日期:2003-09-01 00:00:00

  • Karyotypic changes associated with loss of prolactin dependency of rat Nb2 node lymphoma cell cultures.

    abstract::The parent line of cultured "Nb2 node" lymphoma cells is dependent on the hormone prolactin (PRL) for growth and is widely used for the in vitro bioassay of lactogenic hormones. As reported previously, PRL-independent sublines have been developed in vitro from the parental line by lactogen deprivation. The present stu...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Horsman DE,Masui S,Gout PW

    更新日期:1991-01-01 00:00:00

  • Nuclear translocation of the tumor marker pyruvate kinase M2 induces programmed cell death.

    abstract::Cancer cells often fail to respond to stimuli that normally activate their intrinsic apoptotic machinery. Moreover, they are able to adapt to hypoxia by changing their glycolytic rate. Pyruvate kinase (PK) is a rate-limiting enzyme in glycolysis that is converted to a less active dimer form of PKM2 isoenzyme during on...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-06-2870

    authors: Steták A,Veress R,Ovádi J,Csermely P,Kéri G,Ullrich A

    更新日期:2007-02-15 00:00:00

  • Wilms' tumor 1 gene expression in hepatocellular carcinoma promotes cell dedifferentiation and resistance to chemotherapy.

    abstract::The Wilms' tumor 1 gene (WT1) encodes a transcription factor involved in cell growth and development. As we previously reported, WT1 expression is hardly detectable in normal hepatic tissue but is induced in liver cirrhosis. Although WT1 has been found to be overexpressed in a number of malignancies, the role of WT1 i...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-08-2545

    authors: Perugorria MJ,Castillo J,Latasa MU,Goñi S,Segura V,Sangro B,Prieto J,Avila MA,Berasain C

    更新日期:2009-02-15 00:00:00

  • Human bronchial epithelial cells transformed by the c-raf-1 and c-myc protooncogenes induce multidifferentiated carcinomas in nude mice: a model for lung carcinogenesis.

    abstract::We have previously described the neoplastic transformation of immortalized human bronchial epithelial cells (BEAS-2B) by the combination of the c-raf-1 and c-myc protooncogenes and the concomitant induction of neuron-specific enolase mRNA expression (A. Pfeifer et al., Proc. Natl. Acad. Sci. USA, 86: 10075-10079, 1989...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Pfeifer AM,Jones RT,Bowden PE,Mann D,Spillare E,Klein-Szanto AJ,Trump BF,Harris CC

    更新日期:1991-07-15 00:00:00

  • CD4+ T lymphocytes play a critical role in antibody production and tumor immunity against simian virus 40 large tumor antigen.

    abstract::The role of CD4+ T lymphocytes in antitumor immunity has been largely attributed to providing signals required for the priming of MHC class I-restricted CD8+ cytotoxic T lymphocytes, and CD8+ cytotoxic T lymphocytes are thought to serve as the predominant mediators of tumor killing in vivo. We decided to evaluate the ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Kennedy RC,Shearer MH,Watts AM,Bright RK

    更新日期:2003-03-01 00:00:00

  • Characterization of the biliary and urinary glutathione and N-acetylcysteine metabolites of the hepatic carcinogen 1'-hydroxysafrole and its 1'-oxo metabolite in rats and mice.

    abstract::The hepatocarcinogen safrole is metabolized both to 1'-hydroxysafrole, a proximate hepatocarcinogen, and to 1'-oxosafrole, which is electrophilic but has little or no carcinogenic activity in rats and mice. As a part of a study on the metabolic interrelationships of these metabolites, their biliary and urinary conjuga...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Fennell TR,Miller JA,Miller EC

    更新日期:1984-08-01 00:00:00

  • Detection of the AML1/ETO fusion transcript in the t(8;21) masked translocation in acute myelogenous leukemia.

    abstract::The fusion transcript AML1/ETO was detected in the bone marrow of two t(8;21)-negative acute myelogenous leukemia (AML) patients by means of reverse transcription-polymerase chain reaction. This fusion transcript is identical to the one transcribed from the t(8;21) translocation base, as deduced from (a) the size and ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Maruyama F,Yang P,Stass SA,Cork A,Freireich EJ,Lee MS,Chang KS

    更新日期:1993-10-01 00:00:00

  • Identification of the cross-link between human O6-methylguanine-DNA methyltransferase and chloroethylnitrosourea-treated DNA.

    abstract::Chloroethylnitrosoureas induce reactive O6-guanine adducts in DNA that can form either interstrand cross-links or a covalent complex with the DNA repair protein O6-methylguanine-DNA methyltransferase (MGMT). To test our hypothesis that these end-products are formed from the common precursor, 1-O6-ethanoguanine, we com...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Gonzaga PE,Potter PM,Niu TQ,Yu D,Ludlum DB,Rafferty JA,Margison GP,Brent TP

    更新日期:1992-11-01 00:00:00

  • Interferon-γ Signaling in Melanocytes and Melanoma Cells Regulates Expression of CTLA-4.

    abstract::CTLA4 is a cell surface receptor on T cells that functions as an immune checkpoint molecule to enforce tolerance to cognate antigens. Anti-CTLA4 immunotherapy is highly effective at reactivating T-cell responses against melanoma, which is postulated to be due to targeting CTLA4 on T cells. Here, we report that CTLA4 i...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-17-1615

    authors: Mo X,Zhang H,Preston S,Martin K,Zhou B,Vadalia N,Gamero AM,Soboloff J,Tempera I,Zaidi MR

    更新日期:2018-01-15 00:00:00

  • Inhibition of lymphocyte function in rats fed higher-fat diets.

    abstract::Concanavalin A-induced blastogenesis of spleen lymphocytes was significantly inhibited when lymphocytes from rats on a high-polyunsaturated-fat diet were compared to lymphocytes from rats on a low-fat diet. Responsiveness was dependent on source of serum since lymphocytes from rats fed a low-fat diet were suppressed i...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Kollmorgen GM,Sansing WA,Lehman AA,Fischer G,Longley RE,Alexander SS Jr,King MM,McCay PB

    更新日期:1979-09-01 00:00:00

  • Phase I trial of the amsacrine analogue 9-[( 2-methoxy-4-[(methylsulfonyl)amino]-phenyl]amino)-N,5-dimethyl-4- acridinecarboxamide (CI-921).

    abstract::CI-921, an analogue of amsacrine with superior activity against in vivo and in vitro experimental tumor models, has been studied in 16 patients with solid tumors refractory to chemotherapy or for which conventional therapy does not exist. Thirty-nine cycles were given and doses escalated from 39 to 810 mg/m2. This tot...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Hardy JR,Harvey VJ,Paxton JW,Evans P,Smith S,Grove W,Grillo-Lopez AJ,Baguley BC

    更新日期:1988-11-15 00:00:00

  • Sex-determining region Y box 4 is a transforming oncogene in human prostate cancer cells.

    abstract::Prostate cancer is the most commonly diagnosed noncutaneous neoplasm and second most common cause of cancer-related mortality in western men. To investigate the mechanisms of prostate cancer development and progression, we did expression profiling of human prostate cancer and benign tissues. We show that the SOX4 is o...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-3055

    authors: Liu P,Ramachandran S,Ali Seyed M,Scharer CD,Laycock N,Dalton WB,Williams H,Karanam S,Datta MW,Jaye DL,Moreno CS

    更新日期:2006-04-15 00:00:00

  • HEPSIN inhibits cell growth/invasion in prostate cancer cells.

    abstract::Expression of HEPSIN, a type II transmembrane serine protease in prostate cancer (CaP), has been highlighted by several studies analyzing CaP-specific gene expression alterations by cDNA microarray. Evaluations of the biological functions of HEPSIN in CaP cells are warranted for better assessment of its utility as a b...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Srikantan V,Valladares M,Rhim JS,Moul JW,Srivastava S

    更新日期:2002-12-01 00:00:00

  • Isolation of a prostate carcinoma cell proliferation-inhibiting factor from human seminal plasma and its similarity to transforming growth factor beta.

    abstract::Human seminal plasma (SP) has been known to contain both growth-inhibitory and -stimulatory factors. We attempted to identify a factor that inhibited DNA synthesis in some metastatic prostate cancer cell lines. The SP factor was sensitive to digestion by trypsin, but its activity increased after boiling or dialysis ag...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Lokeshwar BL,Block NL

    更新日期:1992-10-15 00:00:00

  • Combinatorial efficacy achieved through two-point blockade within a signaling pathway-a chemical genetic approach.

    abstract::Whether the apparent efficacy of a specific kinase inhibitor is attributable solely to inhibition of its primary target, or to combined inhibition of additional unidentified kinases, is a critical issue in cancer therapy. We used a chemical genetic approach to generate a selective inhibitor of v-erbB [a transforming a...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Fan QW,Specht KM,Zhang C,Goldenberg DD,Shokat KM,Weiss WA

    更新日期:2003-12-15 00:00:00